NOVATO, Calif.–(BUSINESS WIRE)–QT Imaging Holdings, Inc. (Nasdaq: QTI) (“QT Imaging” or the “Company”), a medical device company dedicated to transforming breast health management through innovative, radiation-free imaging technology, today announced that it will report financial results for the three months ended March 31, 2026 after market close on Wednesday, May 13, 2026 and will hold an investment community conference call that day beginning at 4:30 p.m. Eastern time.
|
Date/Time: |
Wednesday, May 13, 4:30 p.m. ET / 1:30 p.m. PT |
|
|
|
|
|
|
Pre-Registration: |
Participants can pre-register for the conference call here: |
|
|
|
|
|
|
|
Callers who pre-register will be given a conference passcode and unique PIN to gain immediate access to the call and bypass the live operator. Participants may pre-register at any time, including up to and after the call start time. |
|
|
|
|
|
|
Dial In: |
Those who choose not to pre-register can access the live conference call by dialing the following and requesting the QT Imaging call: |
|
|
|
866-777-2509 from within the U.S. |
|
|
|
412-317-5413 from outside the U.S. |
A live and archived webcast of the conference call will be available on the IR Calendar section of the Company website.
About QT Imaging
QT Imaging Holdings, Inc. (Nasdaq: QTI) is a medical device company engaged in the research, development, and commercialization of innovative imaging systems using low frequency sound waves. QT Imaging Holdings, Inc. strives to improve global health outcomes. Its strategy is predicated upon the fact that medical imaging is critical to the detection, diagnosis, and treatment of disease and that it should be safe, affordable, accessible, and centered on the patient’s experience. For more information on QT Imaging Holdings, Inc., please visit the Company’s website at www.qtimaging.com.
Breast Acoustic CT™ is a trademark of an affiliate of QT Imaging Holdings, Inc.
Contacts
Investors
Alliance Advisors IR
Jody Cain
[email protected]
310-691-7107
Media
Alliance Advisors IR
Fatema Bhabrawala
[email protected]
647-620-5002
